As of November 6, 2026, IO Biotech, Inc. has reported 2 exit or restructuring plans to the SEC on Form 8-K under Item 2.05, the latest filed on January 30, 2026. No WARN notice under its name is on file in the states covered here (Form 8-K, January 30, 2026).
12 companies announced layoffs this week.
Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.
| Artiva Biotherapeutics, Inc. | announced layoffs | |
| Eos Energy Enterprises, Inc. | announced layoffs | |
| SOUNDHOUND AI, INC. | announced layoffs | |
| Portillo's Inc. | announced layoffs | |
| Acumen Pharmaceuticals, Inc. | announced layoffs of about 52 employees |
Is this your company?
Owed money by them or selling to them? See the free Snapshot of IO Biotech, Inc.
Free to see. No signup.
IO Biotech, Inc. reported 2 exit or restructuring plans on Form 8-K under Item 2.05. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.
Did IO Biotech have layoffs in 2026? What its filings say
IO Biotech, Inc. (CIK 1865494) reported 2 exit or restructuring plans to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.
Form 8-K filed 2026-01-30
Expected charges
In connection with the implementation of the Plan, the Company expects to incur one-time charges and cash expenditures in a range of approximately $2.4 million to $2.6 million, primarily related to employee wages and severance payments, healthcare continuation, earned vacation time and related termination costs.
Form 8-K filed 2025-09-29
Share of workforce
The Plan is expected to result in a reduction of approximately 50% of the Company's workforce globally.
Expected charges
In connection with the implementation of the Plan, the Company expects to incur one-time charges and cash expenditures in a range of approximately $1.0 million to $1.5 million, primarily related to employee wages and severance payments, healthcare continuation, earned vacation time and related termination costs..
Timing
The Company expects to incur these charges primarily during the third quarter of 2025 and payment of these charges is expected to be completed by the fourth quarter of 2025.
Also on the record for IO Biotech, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| June 2, 2026 | Stake report, Schedule 13D/A, by Lundbeckfond Invest A/S | 27.4% of the class | 5%+ stakes | Source |
| May 20, 2026 | Stake report, Schedule 13G/A, by Chernett Jorey | — | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by Point72 Asset Management, L.P. | — | 5%+ stakes | Source |
| April 6, 2026 | Stake report, Schedule 13G/A, by HBM Healthcare Investments (Cayman) Ltd. | 3.3% of the class | 5%+ stakes | Source |
| March 31, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| February 13, 2026 | Stake report, Schedule 13G/A, by Chernett Jorey | 6.3% of the class | 5%+ stakes | Source |
| February 6, 2026 | Stake report, Schedule 13G, by Point72 Asset Management, L.P. | 5.6% of the class | 5%+ stakes | Source |
| January 23, 2026 | Stake report, Schedule 13D/A, by Novo Holdings A/S | 3.3% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by Vivo Opportunity, LLC | 4.6% of the class | 5%+ stakes | Source |
| November 5, 2025 | Stake report, Schedule 13G, by Chernett Jorey | 5.3% of the class | 5%+ stakes | Source |
| August 19, 2025 | Stake report, Schedule 13D/A, by Novo Holdings A/S | 7.3% of the class | 5%+ stakes | Source |
Keep reading
More on IO Biotech, Inc. and the records around it.
IO Biotech, Inc. elsewhere on the record
- 5%+ stake filings Jun 2026
- Bankruptcy record
Companies that share a holder
- HBM Healthcare Investments (Cayman) Ltd. also filed stake reports on 7 other companies: Chemomab Therapeutics Ltd. (Sep 2026), ALX ONCOLOGY HOLDINGS INC (May 2026), Upstream Bio, Inc. (Nov 2025)
- Novo Holdings A/S also filed stake reports on 11 other companies: Avalyn Pharma Inc. (Aug 2026), Hemab Therapeutics Holdings, Inc. (Aug 2026), Obsidian Therapeutics, Inc. (Aug 2026)
- Chernett Jorey also filed stake reports on 16 other companies: CVRx, Inc. (Oct 2026), WW INTERNATIONAL, INC. (Aug 2026), Neuronetics, Inc. (Aug 2026)
Watch IO Biotech, Inc.
Get an email when IO Biotech, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with IO Biotech, Inc.?
Want the whole picture on IO Biotech, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on IO Biotech, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on IO Biotech, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Tools for this story
Each opens in a new tab, filled in for IO Biotech, Inc.. With no account yet, you sign up free and land on the result.
Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.
Where this comes from
Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.
A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.
Related
- Main Street Sports Group, LLC.: 182 jobs, Feb 2026 layoff notice within 90 days (2026-02-19)
- Republic National Distributing Company, LLC (Reyes Holdings, L.L.C) Grand Prairie: 1 WARN notice, 689 employees, Apr 2026 layoff notice within 90 days (2026-04-23)
- Rising Ground Inc.: 257 jobs, Feb 2026 layoff notice within 90 days (2026-02-20)
- Management & Training Corporation: 1,371 jobs, Apr 2026 layoff notice within 90 days (2026-04-27)
- Innodata Services, LLC: 30 jobs, Feb 2026 layoff notice within 90 days (2026-02-03)
- Republic National Distributing Company, LLC (Reyes Holdings, L.L.C) Corpus Christie: 1 WARN notice, 90 employees, Apr 2026 layoff notice within 90 days (2026-04-23)
Cite this page
https://mentionfox.com/layoffs/io-biotech